MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carmel, Indiana, dedicated to developing precision peptide therapies targeting endocrine and metabolic disorders. Utilizing its proprietary technology platform, MBX is advancing a robust pipeline of innovative therapeutic candidates through rigorous clinical trials to meet significant unmet medical needs. With a commitment to innovation and strategic growth within the biopharmaceutical sector, MBX is well-positioned to deliver transformative solutions for patients while generating value for its stakeholders. Show more

Location: 11711 NORTH MERIDIAN STREET, CARMEL, IN, UNITED STATES, 46032, Carmel, IN, 46032, USA | Website: https://mbxbio.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

1.655B

52 Wk Range

$4.81 - $44.89

Previous Close

$36.84

Open

$36.13

Volume

949,865

Day Range

$36.13 - $38.10

Enterprise Value

1.263B

Cash

223.1M

Avg Qtr Burn

-21.54M

Insider Ownership

2.73%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Canvuparatide (MBX 2109) Details Chronic hypoparathyroidism (HP)	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MBX 1416 Details Post-Bariatric Hypoglycemia	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MBX 4291 Details Obesity	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.